Clinical trial NCT00701168 - References

Neoplasm Metastasis — Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer

Citation(s)

•   Andrews JC, Walker SC, Ackermann RJ, Cotton LA, Ensminger WD, Shapiro B
  Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med. 1994 Oct;35(10):1637-44.
•   Andrews JC, Walker-Andrews SC, Juni JE, Warber S, Ensminger WD
  Modulation of liver tumor blood flow with hepatic arterial epinephrine: a SPECT study. Radiology. 1989 Dec;173(3):645-7.
•   Audisio RA, Doci R, Mazzaferro V, Bellegotti L, Tommasini M, Montalto F, Marchianò A, Piva A, DeFazio C, Damascelli B, et al
  Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis. Cancer. 1990 Jul 15;66(2):228-36.
•   Berger DH, Carrasco CH, Hohn DC, Curley SA
  Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications. J Surg Oncol. 1995 Oct;60(2):116-21.
•   BLANCHARD RJ, GROTENHUIS I, LAFAVE JW, FRYE CW, PERRY JF Jr
  TREATMENT OF EXPERIMENTAL TUMORS; UTILIZATION OF RADIOACTIVE MICROSPHERES. Arch Surg. 1964 Aug;89:406-10.
•   BLANCHARD RJ, GROTENHUIS I, LAFAVE JW, PERRY JF Jr
  BLOOD SUPPLY TO HEPATIC V2 CARCINOMA IMPLANTS AS MEASURED BY RADIOACTIVE MICROSPHERES. Proc Soc Exp Biol Med. 1965 Feb;118:465-8.
•   Blanchard RJ, Morrow IM, Sutherland JB
  Treatment of liver tumors with yttrium-90 microspheres alone. Can Assoc Radiol J. 1989 Aug;40(4):206-10.
•   Boos G, Thirwell M, Blanchard R, et al
  Phase I-II study of hepatic arterial infusion of yttrium-90 (Y-90) glass microspheres in cancer of the liver. Proc Am Soc Clin Oncol. 1989, 8:103.
•   BREEDIS C, YOUNG G
  The blood supply of neoplasms in the liver. Am J Pathol. 1954 Sep-Oct;30(5):969-77.
•   Bruix J, Llovet JM, Castells A, Montañá X, Brú C, Ayuso MC, Vilana R, Rodés J
  Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology. 1998 Jun;27(6):1578-83.
•   Chamberlain MN, Gray BN, Heggie JC, Chmiel RL, Bennett RC
  Hepatic metastases--a physiological approach to treatment. Br J Surg. 1983 Oct;70(10):596-8.
•   Chuang VP
  Hepatic tumor angiography: a subject review. Radiology. 1983 Sep;148(3):633-9.
•   Dancey JE, Shepherd FA, Paul K, Sniderman KW, Houle S, Gabrys J, Hendler AL, Goin JE
  Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med. 2000 Oct;41(10):1673-81.
•   Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT
  NIH conference. Hepatocellular carcinoma. Ann Intern Med. 1988 Mar;108(3):390-401. Review.
•   Douglass C
  Prolongation of survival with periodic percutaneous multi-drug arterial infusions in patients with primary and metastatic gastrointestinal carcinoma to liver, abstracted. Proc Am Soc Clin Oncol. 1980; 21:416
•   Dusheiko GM, Hobbs KE, Dick R, Burroughs AK
  Treatment of small hepatocellular carcinomas. Lancet. 1992 Aug 1;340(8814):285-8. Review.
•   Ehrhardt GJ, Day DE
  Therapeutic use of 90Y microspheres. Int J Rad Appl Instrum B. 1987;14(3):233-42.
•   Gores GJ, Steers JL
  Progress in orthotopic liver transplantation for hepatocellular carcinoma. Gastroenterology. 1993 Jan;104(1):317-20.
•   GRADY ED, SALE WT, ROLLINS LC
  Localization of radioactivity by intravascular injection of large radioactive particles. Ann Surg. 1963 Jan;157:97-114.
•   Gross P
  The effects of fibrous glass dust on the lungs of animals. In: Occupational exposure to fibrous glass of a symposium presented to the Center of Adult Education; 1976; University of Maryland, College Park, MD. 169-178.
•   Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
  A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 1995 May 11;332(19):1256-61.
•   Gyves JW, Ziessman HA, Ensminger WD, Thrall JH, Niederhuber JE, Keyes JW Jr, Walker S
  Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT). J Nucl Med. 1984 Sep;25(9):972-7.
•   Harbert JC, Ziessman HA
  Therapy with intra-arterial microspheres. Nuclear Medicine Annual 1987, edited by Freeman L.M., Weissman H.S. Raven Press, New York.
•   Herba MJ, Illescas FF, Thirlwell MP, Boos GJ, Rosenthall L, Atri M, Bret PM
  Hepatic malignancies: improved treatment with intraarterial Y-90. Radiology. 1988 Nov;169(2):311-4.
•   Hill JW, Whitehead WS, Cameron JD, Hedgecock GA
  Glass fibres: absence of pulmonary hazard in production workers. Br J Ind Med. 1973 Apr;30(2):174-9.
•   Houle S, Yip TK, Shepherd FA, Rotstein LE, Sniderman KW, Theis E, Cawthorn RH, Richmond-Cox K
  Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. Radiology. 1989 Sep;172(3):857-60.
•   Ichihara T, Sakamoto K, Mori K, Akagi M
  Transcatheter arterial chemoembolization therapy for hepatocellular carcinoma using polylactic acid microspheres containing aclarubicin hydrochloride. Cancer Res. 1989 Aug 1;49(15):4357-62.
•   Kassianides C, Kew MC
  The clinical manifestations and natural history of hepatocellular carcinoma. Gastroenterol Clin North Am. 1987 Dec;16(4):553-62. Review.
•   Kirk S, Blumgart R, Craig B, Rosen A, Terblanche J, Spence RA
  Irresectable hepatoma treated by intrahepatic iodized oil doxorubicin hydrochloride: initial results. Surgery. 1991 Jun;109(6):694-7.
•   LAFAVE JW, GROTENHUIS I, KIM YS, MACLEAN LD, PERRY JF Jr
  Y90-tagged microspheres in adjuvant tumor therapy. Surgery. 1963 Jun;53:778-83.
•   Leung TW, Lau WY, Ho SK, Ward SC, Chow JH, Chan MS, Metreweli C, Johnson PJ, Li AK
  Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):919-24.
•   Madden MV, Krige JE, Bailey S, Beningfield SJ, Geddes C, Werner ID, Terblanche J
  Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut. 1993 Nov;34(11):1598-600.
•   Mantravadi RV, Spigos DG, Tan WS, Felix EL
  Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology. 1982 Mar;142(3):783-6.
•   Marcos-Alvarez A, Jenkins RL, Washburn WK, Lewis WD, Stuart KE, Gordon FD, Kane RA, Clouse ME
  Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center. Arch Surg. 1996 Mar;131(3):292-8.
•   Mauderly JL, Pickrell JA, Hobbs CH, Benjamin SA, Hahn FF, Jones RK, Barnes JE
  The effects of inhaled 90Y fused clay aerosol on pulmonary function and related parameters of the beagle dog. Radiat Res. 1973 Oct;56(1):83-96.
•   Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L
  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996 Mar 14;334(11):693-9.
•   Meade VM, Burton MA, Gray BN, Self GW
  Distribution of different sized microspheres in experimental hepatic tumours. Eur J Cancer Clin Oncol. 1987 Jan;23(1):37-41.
•   Nakamura H, Tanaka M, Oi H
  Hepatic embolization from the common hepatic artery using balloon occlusion technique. AJR Am J Roentgenol. 1985 Jul;145(1):115-6.
•   Nerenstone S, Friedman M
  Medical treatment of hepatocellular carcinoma. Gastroenterol Clin North Am. 1987 Dec;16(4):603-12. Review.
•   Patt YZ, Charnsangavej C, Boddie A, et al
  Treatment of hepatocellular carcinoma with hepatic arterial floxuridine, doxorubicin, and mitomycin C (FUDRM) with or without hepatic arterial embolization: factors associated with longer arterial survival. Reg Cancer Treat. 1989; 2:98.
•   Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, Lenoir C, Attali P, Etienne JP
  A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol. 1990 Sep;11(2):181-4.
•   Perry LJ, Stuart K, Stokes KR, Clouse ME
  Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery. 1994 Dec;116(6):1111-6; discussion 1116-7.
•   PRINZMETAL M, ORNITZ EM Jr, et al
  Arterio-venous anastomoses in liver, spleen, and lungs. Am J Physiol. 1948 Jan 1;152(1):48-52.
•   Prinzmetal MB, Simkin B, Bergman HC, Kruger, HE
  Studies on coronary circulation. American Heart Jornal. 1947; 33:420.
•   Ramming KP
  The effectiveness of hepatic artery infusion in treatment of primary hepatobiliary tumors. Semin Oncol. 1983 Jun;10(2):199-205.
•   Ravoet C, Bleiberg H, Gerard B
  Non-surgical treatment of hepatocarcinoma. J Surg Oncol Suppl. 1993;3:104-11. Review.
•   Reed ML, Vaitkevicius VK, Al-Sarraf M, Vaughn CB, Singhakowinta A, Sexon-Porte M, Izbicki R, Baker L, Straatsma GW
  The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: ten-year results of 124 patients in a prospective protocol. Cancer. 1981 Jan 15;47(2):402-9.
•   Russell JL Jr, Carden JL, Herron HL
  Dosimetry calculations for yttrium-90 used in the treatment of liver cancer. Endocurietherapy/Hyperthermia Oncology. 1988; 4:171-186.
•   Sasaki Y, Imaoka S, Kasugai H, Fujita M, Kawamoto S, Ishiguro S, Kojima J, Ishikawa O, Ohigashi H, Furukawa H, et al
  A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer. 1987 Sep 15;60(6):1194-203.
•   SCHENK WG Jr, McDONALD JC, McDONALD K, DRAPANAS T
  Direct measurement of hepatic blood flow in surgical patients: with related observations on hepatic flow dynamics in experimental animals. Ann Surg. 1962 Sep;156:463-71.
•   Selby R, Kadry Z, Carr B, Tzakis A, Madariaga JR, Iwatsuki S
  Liver transplantation for hepatocellular carcinoma. World J Surg. 1995 Jan-Feb;19(1):53-8.
•   Solomon B, Soulen MC, Baum RA, Haskal ZJ, Shlansky-Goldberg RD, Cope C
  Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population. J Vasc Interv Radiol. 1999 Jun;10(6):793-8.
•   Stribley KV, Gray BN, Chmiel RL, Heggie JC, Bennett RC
  Internal radiotherapy for hepatic metastases I: The homogeneity of hepatic arterial blood flow. J Surg Res. 1983 Jan;34(1):17-24.
•   Stribley KV, Gray BN, Chmiel RL, Heggie JC, Bennett RC
  Internal radiotherapy for hepatic metastases II: The blood supply to hepatic metastases. J Surg Res. 1983 Jan;34(1):25-32.
•   Stuart K, Stokes K, Jenkins R, Trey C, Clouse M
  Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization. Cancer. 1993 Dec 1;72(11):3202-9.
•   Stuart K
  Invited commentary on preoperative lipiodol for unresectable HCC. World J Surg 1996; 20:331
•   Stuart KE, Anand AJ, Jenkins RL
  Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer. 1996 Jun 1;77(11):2217-22.
•   Uchida M, Kohno H, Kubota H, Hayashi T, Yamanoi A, Kimoto T, Ono T, Nagasue N
  Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J Surg. 1996 Mar-Apr;20(3):326-31.
•   Venook AP
  Treatment of hepatocellular carcinoma: too many options? J Clin Oncol. 1994 Jun;12(6):1323-34. Review.
•   Vetter D, Wenger JJ, Bergier JM, Doffoel M, Bockel R
  Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a Western comparative study in 60 patients. Hepatology. 1991 Mar;13(3):427-33.
•   Wellwood JM, Cady B, Oberfield RA
  Treatment of primary liver cancer: response to regional chemotherapy. Clin Oncol. 1979 Mar;5(1):25-31.
•   Wollner I, Knutsen C, Smith P, Prieskorn D, Chrisp C, Andrews J, Juni J, Warber S, Klevering J, Crudup J, et al
  Effects of hepatic arterial yttrium 90 glass microspheres in dogs. Cancer. 1988 Apr 1;61(7):1336-44.
•   YA PM, GUZMAN T, LOKEN MK, PERRY JF Jr
  Isotope localization with tagged microspheres. Surgery. 1961 May;49:644-50.
•   Yamada R, Kishi K, Sato M, Sonomura T, Nishida N, Tanaka K, Shioyama Y, Terada M, Kimura M
  Transcatheter arterial chemoembolization (TACE) in the treatment of unresectable liver cancer. World J Surg. 1995 Nov-Dec;19(6):795-800.
•   Ziessman HA, Thrall JH, Gyves JW, Ensminger WD, Niederhuber JE, Tuscan M, Walker S
  Quantitative hepatic arterial perfusion scintigraphy and starch microspheres in cancer chemotherapy. J Nucl Med. 1983 Oct;24(10):871-5.

A Humanitarian Device Exemption Use Protocol of Therasphere® for Treatment of Unresectable Hepatocellular and Metastatic Liver Tumors - HDE #980006

Details for clinical trial NCT00701168